Literature DB >> 21370280

Ephedrine decreases vesicular monoamine transporter-2 function.

Jonathan D Ellis1, Christopher L German, Elisabeth Birdsall, Jarom E Hanson, Marcus A Crosby, Shane D Rowley, Nicole A Sawada, Jeremiah N West, Glen R Hanson, Annette E Fleckenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21370280      PMCID： PMC3546535          DOI： 10.1002/syn.20896

Source DB:  PubMed          Journal:  Synapse        ISSN： 0887-4476            Impact factor:   2.562


× No keyword cloud information.
  15 in total

1.  Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.

Authors:  Kristi S Rau; Elisabeth Birdsall; Trent J Volz; James A Riordan; Anthony J Baucum; Brian P Adair; Rebecca Bitter; James W Gibb; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2006-05-10       Impact factor: 4.030

Review 2.  Amphetamine neurotoxicity: cause and consequence of oxidative stress.

Authors:  Bryan K Yamamoto; Michael G Bankson
Journal:  Crit Rev Neurobiol       Date:  2005

3.  An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.

Authors:  J F Bowyer; G D Newport; W Slikker; B Gough; S A Ferguson; J Tor-Agbidye
Journal:  Toxicol Sci       Date:  2000-05       Impact factor: 4.849

4.  Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; B K Yamamoto
Journal:  Brain Res       Date:  1992-05-29       Impact factor: 3.252

5.  Differential regional effects of methamphetamine on dopamine transport.

Authors:  Pei-Wen Chu; Kristi S Seferian; Elisabeth Birdsall; Jannine G Truong; James A Riordan; Cameron S Metcalf; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2008-05-28       Impact factor: 4.432

6.  Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.

Authors:  Verónica Sandoval; Evan L Riddle; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

7.  Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain.

Authors:  M A Peat; P F Warren; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1983-04       Impact factor: 4.030

8.  In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.

Authors:  Richard B Rothman; Nga Vu; John S Partilla; Bryan L Roth; Sandra J Hufeisen; Beth A Compton-Toth; Jon Birkes; Richard Young; Richard A Glennon
Journal:  J Pharmacol Exp Ther       Date:  2003-09-03       Impact factor: 4.030

9.  The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.

Authors:  David M Thomas; Dina M Francescutti-Verbeem; Donald M Kuhn
Journal:  J Neurochem       Date:  2007-12-06       Impact factor: 5.372

Review 10.  Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.

Authors:  Jeffrey M Brown; Bryan K Yamamoto
Journal:  Pharmacol Ther       Date:  2003-07       Impact factor: 12.310
View more
  1 in total

1.  VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Authors:  P K Multani; R Hodge; M A Estévez; T Abel; H Kung; M Alter; B Brookshire; I Lucki; A H Nall; K Talbot; G A Doyle; F W Lohoff
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.